We are now looking for a paid Research Assistant as master's thesis worker in universal speech enhancement for speech-based health biomarkers.
"I didn't know all the details like I do now, but I knew enough about ALS to know that there wasn't a cure," Gayheart shared. Mekishana Pierre is a news writer at Entertainment Weekly. She has been ...
The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...
Years ago, when venture capitalist Jon Medved took an interest in backing various health tech startups, he had no idea that one day, he would need them to improve his own quality of life. Israel’s ...
The Vermont Clinical and Research ALS Center of Excellence at the University of Vermont Medical Center and the Larner College of Medicine will receive a $20,000 grant to support local families ...
Actor Eric Dane got real about what it’s like to live with ALS, and candidly discussed on Tuesday the range of emotional and physical repercussions of the devastating diagnosis. ALS, or Lou Gehrig’s ...
"This is such a big deal to me, and I want to make sure that people are aware of what ALS is and, more importantly, what we can do to combat it," he said Julia Moore is a TV writer-reporter at PEOPLE.
WASHINGTON — A House bill has been introduced that prioritizes learning why veterans are more likely than those who have not served in the military to develop amyotrophic lateral sclerosis, a fatal ...
Eric Dane depicts life with ALS and the struggles with accepting help from family in one of his first acting roles since being diagnosed with the neurodegenerative disorder. The "Euphoria" and former ...
People in certain states in America appear to be more likely than others to develop devastating neurological diseases, a new study has indicated. Lou Gehrig's disease—also known as amyotrophic lateral ...
In March 2024, Kayla Gonzalez started having an odd sensation behind her right kneecap. At first, she didn’t think much of it. Then, the feeling started to spread. Soon, she had weakness in her calf, ...
Four investigational ALS treatments failed in phase II studies, but CNM-Au8 and pridopidine showed promising trends. The platform trial pooled placebo data across studies, allowing more ALS patients ...